FILE:CVS/CVS-8K-20040804081204.txt.gz
EVENTS:		Financial statements and exhibits
TEXT:
ITEM: 
ITEM: Financial statements and exhibits
 
CVS CORPORATION
Item 7.
                             
Financial Statements and Exhibits
 
(c)
                      
Exhibits
 
99.1
            
Press Release, dated August 4, 2004 of CVS Corporation
 
 
Item 12.
                      
Disclosure of Results of Operations and Financial Condition
 
On August 4, 2004, CVS Corporation issued a press release, announcing its earnings for the second quarter ended July 3, 2004. Attached to this Current Report on Form 8-K as Exhibit 99.1, is a copy of the Corporation's related press release dated August 4, 2004.
 
The information in this report is being furnished, not filed. Accordingly, the information in Item 12 of this report will not be incorporated by reference into any registration statement filed by the Corporation under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference.
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 

Exhibit 99.1
 
 
FOR IMMEDIATE RELEASE
 
WOONSOCKET, RHODE ISLAND, August 4, 2004 - CVS Corporation (NYSE: CVS), today announced record second quarter sales and earnings for the quarter ended July 3, 2004.
 
Net sales for the second quarter ended July 3, 2004 increased 7.7% to $6.94 billion, up from $6.44 billion during the second quarter of 2003. Same store sales (sales from stores open more than one year) for the quarter rose 6.1%, while pharmacy same store sales rose 7.0% and front-end same store sales increased 4.1%. Total pharmacy sales represented 69.1% of total company sales for the quarter.  Third party prescription sales were 93.7% of pharmacy sales for the quarter.
 
Net earnings for the second quarter increased 17.4% to $234.5 million or $0.56 per diluted share, compared with net earnings of $199.8 million or $0.49 per diluted share in the second quarter of 2003.
 
"I am very pleased with our results this quarter," stated Tom Ryan, Chairman of the Board, President, and Chief Executive Officer of CVS Corporation. "We had healthy sales growth as the front-end regained momentum and gross margin performance was better-than-expected. This led to a 17% increase in net earnings, providing further evidence that our core business is thriving."
 
"The completion of the Eckerd acquisition announced earlier this week couldn't have come at a better time for this Company. The integration process has already begun under the leadership of an experienced team, and we look forward to reporting to you on our progress over time," continued Mr. Ryan.
 
, the Company completed the acquisition of approximately 1,260 Eckerd drug stores, located mainly in the southern United States, in addition to Eckerd Health Services, which includes Eckerd's mail order and pharmacy benefit management businesses.
For the second quarter, CVS opened 22 new stores, closed 3 and relocated 17 others.  As of July 3, 2004, CVS operated 4,206 retail and specialty pharmacy stores in 32 states and the District of Columbia. On July 31, 2004
 
The Company will be holding a conference call today for the investment community at 8:30am (EST) to discuss the quarterly results. The call will be simulcast on the Company's web site for all interested parties. To access the webcast, visit the Company's web site at http://investor.CVS.com on the Investor Relations page to hear the call live, or to listen to an archive of the call, which will be available for a one-week period following the call.
stores, its online pharmacy; CVS.com and its pharmacy benefit management and specialty pharmacy subsidiary, PharmaCare Management Services. General information about CVS is available through the Investor Relations portion of the Company's website, at http://investor.CVS.com.
CVS is America's number one retail pharmacy with over 5,000 stores in 36 states and the District of Columbia.  With more than 40 years of dynamic growth in the retail pharmacy industry, CVS is committed to being the easiest pharmacy retailer for customers to use. CVS has created innovative approaches to serve the healthcare needs of all customers through its CVS/pharmacy
 
 
(1) Diluted earnings per common share is computed by dividing (i) net earnings, after accounting for the difference between the dividends on the ESOP preference stock and common stock and after making adjustments for the incentive compensation plans by (ii) Basic shares plus the additional shares that would be issued assuming that all dilutive stock options are exercised and the ESOP preference stock is converted into common stock.  The dilutive earnings adjustment was $1.3 million and $1.6 million for the thirteen weeks ended July 3, 2004 and June 28, 2003 respectively.  The dilutive earnings adjustment was $2.7 million and $3.2 million for the twenty-six weeks ended July 3, 2004 and June 28, 2003 respectively.
 


